Connect Biopharma Holdings Limited Transaction Price Allocated To Remaining Performance Obligations
Connect Biopharma Holdings Limited (CNTB) had Transaction Price Allocated To Remaining Performance Obligations of CNY 174.50 million as of 2024-06-30, per its 6-K filed 2024-09-05.
Discontinued › Notes
ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations · last filed 2024-09-05
- 2024-06-30: Transaction Price Allocated To Remaining Performance Obligations 174.50M CNY.
CNY
| Period end | Transaction Price Allocated To Remaining Performance Obligations |
|---|---|
| 2024-06-30 | 174.50M CNY 6-K · filed 2024-09-05 |
USD
| Period end | Transaction Price Allocated To Remaining Performance Obligations |
|---|---|
| 2024-06-30 | $24.40M 6-K · filed 2024-09-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |